IIM
AGIO icon

INTECH Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

INTECH Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Sell
12,858
-1,171
-8% -$35.5K ﹤0.01% 1368
2026
Q1 		$475K Sell
14,029
-13,798
-50% -$391K ﹤0.01% 1352
2025
Q4 		$757K Buy
27,827
+4,249
+18% +$149K 0.01% 1284
2025
Q3 		$946K Buy
23,578
+785
+3% +$29.5K 0.01% 1199
2025
Q2 		$758K Sell
22,793
-12,496
-35% -$379K 0.01% 1368
2025
Q1 		$1.03M Buy
35,289
+7,041
+25% +$234K 0.01% 1178
2024
Q4 		$928K Buy
28,248
+8,170
+41% +$384K 0.01% 1206
2024
Q3 		$892K Buy
+20,078
New +$912K 0.01% 881

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

INTECH Investment Management's AGIO Position: Q2 2026 in Review

INTECH Investment Management reduced its Agios Pharmaceuticals (AGIO) stake by 8.3% in Q2 2026, selling an estimated $35.5K and leaving 12,858 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

INTECH Investment Management first reported a position in AGIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.03M in Q1 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • INTECH Investment Management held 12,858 shares of Agios Pharmaceuticals worth $477K as of Q2 2026.
  • INTECH Investment Management sold 1,171 Agios Pharmaceuticals shares in Q2 2026, an estimated $35.5K.
  • Agios Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1368 holding.
  • INTECH Investment Management first reported a position in Agios Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Agios Pharmaceuticals position peaked at $1.03M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.